Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin's lymphoma: the survival gain improves as more mature follow-up data become available.

Authors :: Messori A
Bartoli L
Mengato D
Chiumente M
Source :: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2022 May; Vol. 29 (3), pp. e1. Date of Electronic Publication: 2020 Nov 30.
Publication Year :: 2022
Abstract: Competing Interests: Competing interests: None declared.

Subjects :: Follow-Up Studies
Humans
T-Lymphocytes
Lymphoma, Non-Hodgkin therapy
Receptors, Chimeric Antigen

Full Text Access

Tools